Showing results (671-680 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|February 1, 1990
An evaluation of combination 5-fluorouracil and spirogermanium in the treatment of advanced colorectal carcinomaM L McMaster, F A Greco, D H Johnson, et al.
Investigational New Drugs|April 17, 2013
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumorsSunil Sharma, Elisabeth G de Vries, Jeffrey R Infante, et al.
Investigational New Drugs|April 18, 2013
Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumorsChanghoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Investigational New Drugs|February 19, 2013
A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumorsDarren R Feldman, Lawrence H Einhorn, David I Quinn, et al.
Investigational New Drugs|February 19, 2013
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective studyLuca Moscetti, Fabrizio Nelli, Maria A Fabbri, et al.
Investigational New Drugs|September 10, 2013
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patientsSu Jin Lee, Jongtae Lee, Jeeyun Lee, et al.
Investigational New Drugs|July 28, 2014
Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicitiesDawn N Waterhouse, Brent W Sutherland, Nancy Dos Santos, et al.
Investigational New Drugs|July 1, 1989
2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivoR Saydjari, J R Upp, R W Alexander, et al.
Investigational New Drugs|July 1, 1989
Heterogeneous survival and cell kinetics responses of human astrocytoma clones to alpha-difluoromethylornithine in vitroS C Barranco, P J Ford, C M Townsend
Investigational New Drugs|August 1, 2014
"Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183"Serena Marchetti, Dick Pluim, Jos H Beijnen, et al.
Pageof 372